Walleye Trading Advisors »

Fulcrum Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 108k 11.31
2024-09-30 $59k 17k 3.57

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Microsoft Corporation (MSFT)
Boston Scientific Corporation (BSX)
Spdr Gold Tr Gold Shs (GLD)
Bank of America Corporation (BAC)
Tesla Motors (TSLA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ford Mtr Note 3/1 (Principal)
Intuitive Surgical Com New (ISRG)

View all positions for Walleye Trading Advisors

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Point72 Asset Management
First Turn Management
Balyasny Asset Management
D. E. Shaw & Co
Ikarian Capital
ADAR1 Capital Management
Standard Life Aberdeen

View all funds holding Fulcrum Therapeutics